10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Adam Taich, CFO, indicated that revenue guidance cut was influenced by macroeconomic factors and internal commercial reorganization. The company expects stable gross margins with new products and aims for cash flow positivity.

Read More

Did you find this insightful?